Not applicableStudy completedNCT01471535What this trial is testingHBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon TreatedWho this might be right forChronic Hepatitis B Beijing Ditan Hospital 20
Not applicableUnknownNCT04959643What this trial is testingSystematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University HospitalWho this might be right forHepatitis CHepatitis BAddiction University Hospital, Montpellier 600
Testing effectiveness (Phase 2)Study completedNCT00698906What this trial is testingComparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 yWho this might be right forHepatitis B GlaxoSmithKline 160
Not applicableLooking for participantsNCT07491848What this trial is testingOral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+DWho this might be right forHEPATITIS B CHRONICHepatitis DPeriodontitis Research Center of Periodontal-Systemic Interactions 25
Not applicableStudy completedNCT04371276What this trial is testingSeroepidemiology of Viral Hepatitis in Hong KongWho this might be right forViral Hepatitis Chinese University of Hong Kong 2,888
Large-scale testing (Phase 3)Study completedNCT00352963What this trial is testingImmunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).Who this might be right forPoliomyelitisTetanusAcellular Pertussis+2 more GlaxoSmithKline 480
Not applicableStudy completedNCT00158717What this trial is testingObservational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.Who this might be right forHepatitis B Gilead Sciences 107
Testing effectiveness (Phase 2)Study completedNCT01795911What this trial is testingSafety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With RibavirinWho this might be right forHepatitis C Bristol-Myers Squibb 165
Not applicableUnknownNCT01441609What this trial is testingExpression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B VaccinationWho this might be right forHepatitis B Beijing Municipal Science & Technology Commission 94
Testing effectiveness (Phase 2)Study completedNCT04535544What this trial is testingJNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D VirusWho this might be right forHepatitis D, Chronic Janssen Research & Development, LLC 52
Large-scale testing (Phase 3)Study completedNCT00275652What this trial is testingA Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.Who this might be right forHepatitis BCirrhosis Mayo Clinic 6
Large-scale testing (Phase 3)Study completedNCT00197249What this trial is testingComparative Study in Healthy Adults Aged 18-50 Yrs Administered With Hepatyrix or Havrix+Typherix or Tiphim Vi, to Compare Reactogenicity & ImmunogenicityWho this might be right forHepatitis A GlaxoSmithKline 1,034
Testing effectiveness (Phase 2)Study completedNCT00317174What this trial is testingAssess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.Who this might be right forHaemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more GlaxoSmithKline 450
Not applicableNot Yet RecruitingNCT06926647What this trial is testingA Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis BWho this might be right forHBVChronic Hepatitis b Beijing 302 Hospital 2,000
Large-scale testing (Phase 3)Study completedNCT00315055What this trial is testingImmunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months ScheduleWho this might be right forHepatitis BPolioDiphtheria+1 more Sanofi Pasteur, a Sanofi Company 310
Not applicableStudy completedNCT02596438What this trial is testingThousand Asian American StudyWho this might be right forHepatitis B University of California, Davis 1,076
Testing effectiveness (Phase 2)Ended earlyNCT02065336What this trial is testingStudy to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionWho this might be right forHepatitis B, Chronic Arrowhead Pharmaceuticals 58
Post-approval studies (Phase 4)UnknownNCT03448744What this trial is testingEfficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced PatientsWho this might be right forChronic Hepatitis b Wen-hong Zhang 240
Not applicableEnded earlyNCT01794234What this trial is testingAn Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) AnaloguesWho this might be right forHepatitis B, Chronic Hoffmann-La Roche 44
Post-approval studies (Phase 4)Study completedNCT01821547What this trial is testingNew Methods to Measure the Immune Response to Hepatitis B VaccineWho this might be right forHepatitis B University of Oxford 21